Health Care Select Sector SPDR Fund vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? Health Care Select Sector SPDR Fund trades at $160.19, while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.64. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| XLV | YMAG | |
|---|---|---|
52-Week High | $164.48 | $15.98 |
52-Week Low | $129.01 | $11.00 |
Sector | — | Income / Options Overlay |
Signals from Pluang's Aura AI — not financial advice
XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.
XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.
YMAG trades at $11.63, up 0.17% with a bearish technical signal from moving averages. The ETF provides weekly distributions, recently ranging from $0.07 to $0.40 per share, targeting income through covered calls on Magnificent Seven stocks. Key financial ratios are unavailable, limiting fundamental assessment. Recent news highlights distribution announcements and strategy discussions amid mixed sentiment regarding its performance versus peers.
Outlook hinges on volatility monetization via options, offering high yield but facing NAV decay risks. Investment appeal lies in income generation during range-bound markets, though underperformance in rising equity environments and high expenses pose challenges. Risks include dependency on underlying stock volatility and competitive ETF pressure.
Trailing returns across standard periods
Latest headlines on both assets
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →